On December 5, Senators Warren and Grassley sent a letter to the Acting FDA Commissioner, Brett Giroir, MD, pointing out the fact that the FDA previously announced that over-the-counter (OTC) hearing aid rules would be a priority on their fall 2018 Unified Agenda and they would likely deliver the proposed rules well in advance of the August 2020 statutory deadline. Senators Warren and Grassley note that “it is now December 2019 and we have yet to see these regulations come to fruition.”
Citing the serious nature of hearing difficulties and the related conditions that frequently accompany them, the letter requests that the FDA provide an update on the status of the OTC hearing aid rules and regulations and when the FDA expects to finalize the OTC hearing aid rules no later than December 19, 2019.
Recent Posts
When Audiologists Lead, Patients Win
Level Up Your Practice at AAA 2026—Bring Your Assistant and Take Advantage of Exclusive Package Discounts! The Audiology Assistant Track is back by popular demand at AAA 2026,…
Utah Committee Removes Audiology Deregulation Language After Strong Professional Pushback
Early last week, the Utah Office of Professional Licensing Review (OPLR) released draft legislation proposing major revisions to the regulatory framework for licensure of multiple…
Academy Joins National Push for Inclusive Loan Rules for Health Professions
Late last month, the Academy signed onto a letter to the Department of Education and the Reimagining and Improving Student Education (RISE) rulemaking committee urging…
